{"id":247598,"date":"2026-04-13T14:22:16","date_gmt":"2026-04-13T14:22:16","guid":{"rendered":"https:\/\/www.newsbeep.com\/us-tx\/247598\/"},"modified":"2026-04-13T14:22:16","modified_gmt":"2026-04-13T14:22:16","slug":"20-posts-not-to-miss-from-texas-lung-cancer-conference-2026","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us-tx\/247598\/","title":{"rendered":"20 Posts Not To Miss From Texas Lung Cancer Conference 2026"},"content":{"rendered":"<p><a href=\"https:\/\/thetlcconference.com\/\" target=\"_blank\" rel=\"noopener nofollow\">The Texas Lung Cancer Conference 2026<\/a> took place from April 9 to 11 at ACL Live at The Moody Theater in Austin, Texas, bringing together leading voices in thoracic oncology for three days of scientific exchange and multidisciplinary discussion. Chaired by Dr. Tina Cascone and Dr. Stephen Liu, the meeting convened more than 100 experts to examine current developments in lung cancer research, clinical practice, and emerging therapeutic strategies.<\/p>\n<p>The conference program began on Thursday evening, April 9, with a Welcome Reception and poster competition, setting the tone for broader academic engagement throughout the meeting. At a time when thoracic oncology was continuing to evolve rapidly, the Texas Lung Cancer Conference served as an important forum for reviewing new evidence, sharing expert perspectives, and strengthening collaboration across the lung cancer community.<\/p>\n<p>Here are 20 insightful posts you shouldn\u2019t miss from leading experts highlighting key perspectives, research updates, and important discussions shared during the Texas Lung Cancer Conference 2026.<\/p>\n<p>20 Posts Not To Miss From Texas Lung Cancer Conference<\/p>\n<p><a href=\"https:\/\/www.linkedin.com\/posts\/misty-shields-5b9b1478_sclc-nsclc-meded-activity-7448829544129597440-J8g-?utm_source=social_share_send&amp;utm_medium=member_desktop_web&amp;rcm=ACoAAEkPxQoB6bvJhq-cJDWpeyMqoJQufKhzggQ\" target=\"_blank\" rel=\"noopener nofollow\">Misty Shields:<\/a><\/p>\n<p>\u201cThe fourth annual Texas Lung Cancer Conference LIVE from ACL was fabulous! Thank you to Dr. Stephen Liu &amp; Dr. Tina Cascone for the invitation and the wonderful IDEOlogy Health\u2122 team as such fantastic hosts! Grateful for a thoracic oncology community that is TRULY family!\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483604\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/1775939350306-1-800x600.webp.webp\" alt=\"Lung cancee\" width=\"551\" height=\"414\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 2\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/DrewMoghanaki\" rel=\"nofollow\">Drew Moghanaki:<\/a><\/p>\n<p>\u201cToday was the first time I observed Salma Jabbour in a debate. It wouldn\u2019t have mattered who was on the other side as she was absolutely spectacular using data and logic to clarify CRT is often the better local therapy for bulky T4N2 NSCLC.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483606\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/HFqFEInXMAAi7BP-600x800.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"445\" height=\"593\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 3\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/JoeChangMD\/status\/2043152805926412706?s=20\" rel=\"nofollow\">Joe Y Chang:<\/a><\/p>\n<p>\u201cTexas lung cancer day 2: What is the role of radiotherapy vs. surgery in stage III NSCLC in the era of IO? In the debate about RT Salma Jabbour vs. surgery Brendon Stiles, RT won in the case of T4 N2M0 NSCLC. Representatives from RT and Surgery did a great job inspiring lung cancer colleagues about optimizing local TX with novel systemic TX. Ultimately, we need to answer the question of what we can\/should offer to our patients, including our family members. Congratulations on a very successful IASLC.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483609\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/HFq8gJKXAAANFWM-800x600.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"618\" height=\"464\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 4\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/heidi_onda\/status\/2042449649722667355?s=20\" rel=\"nofollow\">Heidi Nafman-Onda:<\/a><\/p>\n<p>\u201cArrived at Texas Lung 26 bumping into absolute rockstars in thoracic oncology. Pinch me-being in the same room with people who are changing the story of lung cancer every day. Grateful to be here. Let\u2019s go! \u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483611\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/4444-800x600.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"585\" height=\"439\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 5\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/BenCreelan\/status\/2042965474468667497?s=20\" rel=\"nofollow\">Ben Creelan:<\/a><\/p>\n<p>\u201cKicking off day 2 Texas Lung 26: Iyengar Puneeth shows outstanding questions in SCLC: What is a role of PCI now in limited stage? Should we still use consolidation RT in extensive disease?\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483617\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/000-800x493.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"613\" height=\"378\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 6\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/lungoncdoc\/status\/2043066870366949707?s=20\" rel=\"nofollow\">Eric K. Singhi:<\/a><\/p>\n<p>\u201cEGFR+ NSCLC to SCLC: what to do today? 1. Prioritize clinical trial 2. If no trial, chemo + TKI 3. Tarlatamab not the \u201cblockbuster\u201d solution for most pts but DLL3 expression might help us.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483621\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/88-600x800.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"420\" height=\"560\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 7\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/jennifermarksmd\/status\/2043092980622385468?s=20\" rel=\"nofollow\">Jennifer A. Marks:<\/a><\/p>\n<p>\u201cTexas Lung 26 Hold \u2018Em Debate.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483623\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/HFqGLvUXQAAcCYE-800x600.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"527\" height=\"395\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 8\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/NarjustFlorezMD\/status\/2043077732293112245?s=20\" rel=\"nofollow\">Narjust Florez: <\/a><\/p>\n<p>\u201cFrom EGFR to ALK to RET, adjuvant therapy in lung cancer is evolving fast. ADAURA, ALINA, and LIBRETTO-432 are redefining what \u201ccurative intent\u201d can look like after surgery. The question is no longer if we should treat, but who, when, and how long.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483626\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/090909-598x800.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"478\" height=\"639\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 9\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/chulkimMD\/status\/2043091578021933177?s=20\" rel=\"nofollow\">Chul Kim: <\/a><\/p>\n<p>\u201cAnother memorable Texas Lung debate: T4N2 NSCLC: periop chemoIO approach vs. chemoRT\u2192IO. Dr. Salma Jabbour takes the trophy home. Both Drs. Brendon Stiles &amp; Jabbour made a strong case and agreed that multi-D discussion &amp; shared decision-making with patients remain key.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483627\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/lllllll-800x600.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"581\" height=\"436\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 10\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/BalazsHalmosMD\/status\/2042714286561075325?s=20\" rel=\"nofollow\">Balazs Halmos:<\/a><\/p>\n<p>\u201cLung cancer- be warned! This is the thoracic team searching for you day and night to protect our patients in Da Bronx!\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483629\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/HFkt0RSXgAADNgZ-525x800.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"374\" height=\"570\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 11\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/ipreeshagul\/status\/2043068549636252136?s=20\" rel=\"nofollow\">Isabel Preeshagul<\/a>:\u00a0<\/p>\n<p>\u201cTransformed small cell\u2026 best practices below by Dr Carl Gay 1L platinum etop + osi 2L if DLL3 greater than 50% consider tarla + tki, if less , consider lurbi osi Most important message \u2013 consider a trial here! This space is in dire need of support !\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483634\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/ppppp-600x800.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"466\" height=\"621\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 12\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/KCargillMDPhD\/status\/2043100778768863548?s=20\" rel=\"nofollow\">\u00a0Kasey Cargill:<\/a><\/p>\n<p>\u201d Thank you to Dr. Tina Cascone and Stephen Liu<br \/>for bringing together experts in thoracic oncology with the shared goal of innovative, patient-centered care at the 2026. It was a privilege to share my work as a poster competition winner!\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483636\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/HFqNUuYXcAAC7rw-800x600.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"524\" height=\"393\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 13\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/ClayReedMD\/status\/2043079215554101485?s=20\" rel=\"nofollow\">Clay Reed:<\/a><\/p>\n<p>\u201cMore like Brendon \u201cStyles\u201d Brendon Stiles , Texas Lung Hold \u2018Em Debate: Surgical vs Non-surgical Approaches to Early-Stage Lung Cancer\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483644\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/HFp5txaXMAAGNap-800x600.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"620\" height=\"465\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 14\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/yajur_arya\/status\/2042991223036653859?s=20\" rel=\"nofollow\">Yajur Arya:<\/a><\/p>\n<p>\u201cHad a fantastic experience at Texas Lung 26. Honored to present my research and learn from leaders advancing lung cancer care for our patients. Sincere thanks to Rami Manochakian for the invaluable mentorship, and to Stephen Liu and Tina Cascone for curating an outstanding meeting.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483821\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/HFopr2NWgAAHQlj-800x450.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"584\" height=\"328\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 15\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/Latinamd\/status\/2042972016186184116?s=20\" rel=\"nofollow\">Estela Rodriguez:<\/a><\/p>\n<p>\u201cMPM26 Lung cancer advocacy in action at the 3rd Biennial Miami Precision Medicine Conference- lung cancer survivors are a living proof of why research matters precision oncology biomaker testing in cancer \u201d<\/p>\n<p><a href=\"https:\/\/x.com\/StephenVLiu\/status\/2042434576581087520?s=20\" rel=\"nofollow\">Stephen V Liu:<\/a><\/p>\n<p>\u201cSome amazing posters from such talented trainees and junior faculty at the Welcome Poster Reception for Texas Lung 26! Day 1 of TLC conference is tomorrow at acl live! \u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483826\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/HFgva20W4AA2g33-800x600.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"743\" height=\"557\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 16\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/lungoncdoc\/status\/2043160081781436910?s=20\" rel=\"nofollow\">Eric K. Singhi:<\/a><\/p>\n<p>\u201cCongratulations to Stephen Liu &amp; Tina Cascone on a very successful Texas Lung 26. Raising the bar every single year.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483830\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/HFrDQywWQAAsKLk-1-600x800.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"521\" height=\"695\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 17\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/BenCreelan\/status\/2042984370483417224?s=20\" rel=\"nofollow\">Ben Creelan:<\/a><\/p>\n<p>\u201cHigh quality study from Benjamin Besse showing only 26% of pts need retreatment after getting 2 yrs pembro for NSCLC. However, outcome for IO rechallenge was mixed, w\/ many pts clearly not responding and dying. Much like CM-153 &amp; w\/ prior pooled report of Abreu-Rodriguez showing only 19-27% ORR with pembro re-challenge. So still an unresolved question: whether 2-yr discontinuation is optimal for all patients? \u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483833\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/HFoiDuyakAUOuK9-800x420.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"632\" height=\"332\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 18\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/lungoncdoc\/status\/2042999778879984064?s=20\" rel=\"nofollow\">Eric K. Singhi:<\/a><\/p>\n<p>\u201cI have SO much respect for Dr. Stephen Liu . Not only is he an amazing clinician who is deeply compassionate, but he is truly one of the very BEST communicators in our field. And that matters now more than ever. Grateful for all you do and for the invite Texas Lung 26.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483834\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/HFoxdZSakAMDg4Q-600x800.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"482\" height=\"643\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 19\"  \/><\/p>\n<p><a href=\"https:\/\/x.com\/drshieldsmd\/status\/2041707938713145828?s=20\" rel=\"nofollow\">Misty Dawn Shields:<\/a><\/p>\n<p>\u201cThe 4th annual Texas Lung Cancer Conference TLCconference Texas Lung 26 kicks off in just over day! TBH: One of the BEST high-impact conferences you will ever attend, plus it\u2019s held at the Moody Theater! Hosted by co-chairs Stephen Liu &amp; Tina Cascone, and supported by the stellar team at IDEOlogy Health. Texas Lung Hold \u2018Em Debate Dealer Joshua Sabari, Brendon Stiles vs. Salma Jabbour. \u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-483835\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/04\/mmmm-800x600.webp.webp\" alt=\"Lung Cancer - OncoDaily\" width=\"611\" height=\"458\" title=\"20 Posts Not To Miss From Texas Lung Cancer Conference 2026 20\"  \/><\/p>\n<p style=\"text-align: right\">Explore more oncology news and features on <a href=\"https:\/\/oncodaily.com\/\" rel=\"nofollow noopener\" target=\"_blank\">OncoDaily<\/a>.<\/p>\n<p style=\"text-align: right\">Written by Nare Hovhannisyan,MD<\/p>\n","protected":false},"excerpt":{"rendered":"The Texas Lung Cancer Conference 2026 took place from April 9 to 11 at ACL Live at The&hellip;\n","protected":false},"author":2,"featured_media":247599,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[27,29,28],"class_list":["post-247598","post","type-post","status-publish","format-standard","has-post-thumbnail","category-texas","tag-texas","tag-texas-headlines","tag-texas-news"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts\/247598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/comments?post=247598"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts\/247598\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/media\/247599"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/media?parent=247598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/categories?post=247598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/tags?post=247598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}